Literature DB >> 20599362

The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study.

Ian M Anderson1, Gabriella Juhasz, Emma Thomas, Darragh Downey, Shane McKie, J F William Deakin, Rebecca Elliott.   

Abstract

Both reduced serotonergic (5-HT) function and negative emotional biases have been associated with vulnerability to depression. In order to investigate whether these might be related we examined 5-HT modulation of affective processing in 14 remitted depressed subjects compared with 12 never depressed controls matched for age and sex. Participants underwent function magnetic resonance imaging (fMRI) during a covert face emotion task with and without intravenous citalopram (7.5mg) pretreatment. Compared with viewing neutral faces, and irrespective of group, citalopram enhanced left anterior cingulate blood oxygen level dependent (BOLD) response to happy faces, right posterior insula and right lateral orbitofrontal responses to sad faces, and reduced amygdala responses bilaterally to fearful faces. In controls, relative to remitted depressed subjects, citalopram increased bilateral hippocampal responses to happy faces and increased right anterior insula response to sad faces. These findings were not accounted for by changes in BOLD responses to viewing neutral faces. These results are consistent with previous findings showing 5-HT modulation of affective processing; differences found in previously depressed participants compared with controls may contribute to emotional processing biases underlying vulnerability to depressive relapse.
Copyright © 2010 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20599362     DOI: 10.1016/j.euroneuro.2010.06.008

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  18 in total

1.  Music in depression: Neural correlates of emotional experience in remitted depression.

Authors:  Sabine Aust; Karin Filip; Stefan Koelsch; Simone Grimm; Malek Bajbouj
Journal:  World J Psychiatry       Date:  2013-06-22

2.  Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging.

Authors:  Danny J J Wang; Yufen Chen; María A Fernández-Seara; John A Detre
Journal:  J Pharmacol Exp Ther       Date:  2011-02-11       Impact factor: 4.030

3.  fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.

Authors:  Jeffrey Morris Miller; Noam Schneck; Greg J Siegle; Yakuan Chen; R Todd Ogden; Toshiaki Kikuchi; Maria A Oquendo; J John Mann; Ramin V Parsey
Journal:  Psychiatry Res       Date:  2013-12-30       Impact factor: 3.222

4.  MDMA enhances emotional empathy and prosocial behavior.

Authors:  Cédric M Hysek; Yasmin Schmid; Linda D Simmler; Gregor Domes; Markus Heinrichs; Christoph Eisenegger; Katrin H Preller; Boris B Quednow; Matthias E Liechti
Journal:  Soc Cogn Affect Neurosci       Date:  2013-10-04       Impact factor: 3.436

5.  A face a mother could love: depression-related maternal neural responses to infant emotion faces.

Authors:  Heidemarie K Laurent; Jennifer C Ablow
Journal:  Soc Neurosci       Date:  2013-01-21       Impact factor: 2.083

6.  Endogenous serotonin facilitates hippocampal long-term potentiation at CA3/CA1 synapses.

Authors:  Boris Mlinar; Gabriella Stocca; Renato Corradetti
Journal:  J Neural Transm (Vienna)       Date:  2014-05-29       Impact factor: 3.575

Review 7.  A neurocognitive model for understanding treatment action in depression.

Authors:  Matthew B Warren; Abbie Pringle; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

Review 8.  Cognitive mechanisms of treatment in depression.

Authors:  Jonathan P Roiser; Rebecca Elliott; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

9.  Functional anomalies in healthy individuals with a first degree family history of major depressive disorder.

Authors:  Francesco Amico; Angela Carballedo; Danuta Lisiecka; Andrew J Fagan; Gerard Boyle; Thomas Frodl
Journal:  Biol Mood Anxiety Disord       Date:  2012-01-12

10.  FRAS1-related extracellular matrix 3 (FREM3) single-nucleotide polymorphism effects on gene expression, amygdala reactivity and perceptual processing speed: An accelerated aging pathway of depression risk.

Authors:  Yuliya S Nikolova; Swetha P Iruku; Chien-Wei Lin; Emily Drabant Conley; Rachel Puralewski; Beverly French; Ahmad R Hariri; Etienne Sibille
Journal:  Front Psychol       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.